论文部分内容阅读
肺心病是呼吸系统的常见疾病,虽然近年来它的发病机制和治疗研究已取得了很大进展,但是发病率和病死率仍较高。体液因子与肺心病发病的相关性研究已逐渐深入,最近发现尾加压素Ⅱ与肺心病的发生、发展及预后可能密切相关。尾加压素Ⅱ拮抗剂的研究也许可揭示肺心病患者的发病机制,为肺心病的治疗提供新的方向。现就尾加压素Ⅱ与肺心病关系的研究进展简要综述。
Pulmonary heart disease is a common respiratory disease, although its pathogenesis and treatment of recent years has made great progress in research, but the incidence and mortality is still high. The relationship between humoral factors and the pathogenesis of pulmonary heart disease has been gradually deepened. Recently, it was found that urotensin II may be closely related to the occurrence, development and prognosis of pulmonary heart disease. Urotensin II antagonist research may reveal the pathogenesis of patients with pulmonary heart disease, provide a new direction for the treatment of pulmonary heart disease. A Brief Review on the Research Progress of the Relationship between Urotensin Ⅱ and Pulmonary Heart Disease.